BlackRock’s Cymabay Therapeutics CBAY Stock Holding History

BlackRock’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,610,239	Closed	-$227M	–	5323
2023 Q4	$227M	Buy	9,610,239 +1,818,243	+23%	+$42.9M	0.01%	1555
2023 Q3	$116M	Buy	7,791,996 +287,326	+4%	+$4.28M	﹤0.01%	1888
2023 Q2	$82.2M	Buy	7,504,670 +4,854,593	+183%	+$53.2M	﹤0.01%	2147
2023 Q1	$23.1M	Buy	2,650,077 +634,577	+31%	+$5.53M	﹤0.01%	2849
2022 Q4	$12.6M	Buy	2,015,500 +70,850	+4%	+$444K	﹤0.01%	3218
2022 Q3	$6.81M	Sell	1,944,650 -8,219	-0.4%	-$28.8K	﹤0.01%	3549
2022 Q2	$5.76M	Sell	1,952,869 -3,513,340	-64%	-$10.4M	﹤0.01%	3680
2022 Q1	$17M	Buy	5,466,209 +142,081	+3%	+$442K	﹤0.01%	3206
2021 Q4	$18M	Buy	5,324,128 +118,650	+2%	+$401K	﹤0.01%	3276
2021 Q3	$19M	Sell	5,205,478 -226,192	-4%	-$826K	﹤0.01%	3259
2021 Q2	$23.7M	Sell	5,431,670 -526,818	-9%	-$2.3M	﹤0.01%	3149
2021 Q1	$27.1M	Buy	5,958,488 +572,244	+11%	+$2.6M	﹤0.01%	2968
2020 Q4	$30.9M	Buy	5,386,244 +255,336	+5%	+$1.47M	﹤0.01%	2716
2020 Q3	$37.1M	Sell	5,130,908 -485,654	-9%	-$3.52M	﹤0.01%	2414
2020 Q2	$19.6M	Buy	5,616,562 +84,974	+2%	+$297K	﹤0.01%	2763
2020 Q1	$8.19M	Sell	5,531,588 -58,263	-1%	-$86.2K	﹤0.01%	3052
2019 Q4	$11M	Sell	5,589,851 -38,388	-0.7%	-$75.2K	﹤0.01%	3160
2019 Q3	$28.8M	Buy	5,628,239 +97,547	+2%	+$499K	﹤0.01%	2586
2019 Q2	$39.6M	Buy	5,530,692 +493,662	+10%	+$3.53M	﹤0.01%	2438
2019 Q1	$66.9M	Sell	5,037,030 -124,551	-2%	-$1.65M	﹤0.01%	2108
2018 Q4	$40.6M	Buy	5,161,581 +722,753	+16%	+$5.69M	﹤0.01%	2352
2018 Q3	$49.2M	Buy	4,438,828 +384,543	+9%	+$4.26M	﹤0.01%	2368
2018 Q2	$54.4M	Buy	4,054,285 +2,885,082	+247%	+$38.7M	﹤0.01%	2294
2018 Q1	$15.2M	Buy	1,169,203 +478,524	+69%	+$6.22M	﹤0.01%	2889
2017 Q4	$6.35M	Buy	690,679 +77,459	+13%	+$713K	﹤0.01%	3316
2017 Q3	$4.94M	Buy	613,220 +431,896	+238%	+$3.48M	﹤0.01%	3414
2017 Q2	$1.05M	Buy	181,324 +61,979	+52%	+$357K	﹤0.01%	3791
2017 Q1	$513K	Buy	+119,345	New	+$513K	﹤0.01%	3906